Lenacapavir is one of the latest HIV-prevention drugs that health experts are looking to, in the effort to end the HIV epidemic. Reporter Leah Kahunde Ndung’u examines what Lenacapavir’s rollout could mean for Uganda — one of two trial countries in Africa.
The story you just read is not locked behind a paywall because listeners and readers like you generously support our nonprofit newsroom. Now more than ever, we need your help to support our global reporting work and power the future of The World. Can we count on you?